Public health and WHOStudies updated this monthWho chooses your treatment? The benefits of medicines are sometimes exaggerated!
What do Natural Therapy Specialists write?
The industry influences research, health policy, guidelines, medical practice, and patient decisions.
The industry influences both staff training and the decisions made by staff and patients.
The benefits of medicines are sometimes exaggerated and possible harms downplayed, leading to biased guidelines and decisions.
Jerzy Zięba describes doctors’ training as focused on new medicines, and universities as dependent on pharmaceutical companies’ money.
Jerzy Zięba asks whether the new minister will resist pressure from the industry. He also describes company representatives visiting pharmacies, where they can review data on prescriptions.
Jerzy Zięba believes that the media’s dependence on pharmaceutical company advertising makes it difficult to publish critical information about their actions.
Jerzy Zięba says a publisher may decide not to publish something in order to maintain good relations with advertisers and medical authorities.
Jerzy Zięba claims that the number of vaccinations is planned to keep increasing and that the same doses of medicines are to be used for all patients.
Jerzy Zięba emphasizes that clinical trial procedures are intended to protect patients from the harmful effects of introducing medicines.
Jerzy Zięba questions whether vaccine clinical trials meet the standards he considers necessary.
The STOP NOP Association says that industry-sponsored research is used to develop medicines and vaccines and to train staff.
Henryk Różański describes companies’ efforts to remove natural products that compete with their products from the market.
Hubert Czerniak presents the sale of cancer medicines as a business in which profit may take precedence over lasting cures.
Jerzy Zięba acknowledges that academic medicine and the pharmaceutical industry effectively save lives in emergencies.
Jerzy Zięba emphasizes that academic medicine and the pharmaceutical industry effectively save lives in cases of sudden health problems.
What does scientific research from PubMed · Europe PMC say?
We selected 6 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 1 282.
Aim of the study: The relationship between physicians and the pharmaceutical industry has evolved significantly over the years, raising concerns about ethical practices in medical prescribing. This article explores the multifaceted influence of pharmaceutical companies on physician behaviour, highlighting how marketing strategies, financial incentives, and promotional activities can compromise the integrity of clinical decision-making.
Results: This article explores the multifaceted influence of pharmaceutical companies on physician behaviour, highlighting how marketing strategies, financial incentives, and promotional activities can compromise the integrity of clinical decision-making. Through a comprehensive review of the literature, the article examines the implications of inculcating ethics in undergraduate medical programmes, so future healthcare professionals understand the importance of making evidence-based decisions. Furthermore, this article calls for a critical evaluation of existing regulatory frameworks and advocates for stronger ethical guidelines to ensure that physician prescriptions are based solely on patient needs rather than external pressures from the pharmaceutical industry. Ultimately, it emphasizes the importance of restoring ethical standards in medicine to safeguard patient welfare and maintain the sanctity of the physician-patient relationship.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: To increase nurse practitioners' (NPs) awareness of the conflict of interest that exists between the NPs' primary goal of making the best medication choices for patients and the potentially negative impact that the pharmaceutical industry's marketing strategies have on these choices.
Results: Healthcare professionals are given gifts, dinners, and other inducements in the drug industry's effort to increase consumerism and drug sales. The current method of drug promotion increases sales but also increases healthcare expenses. Research also indicates that the pharmaceutical marketing strategies influence the judgments that NPs and other healthcare professionals make about patient care and drug prescriptions.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health. These guidelines, which are based on systematic methods to evaluate and classify evidence, provide a foundation for the delivery of quality cardiovascular care.
Results: Hyperlinked references are provided for each modular knowledge chunk to facilitate quick access and review. More structured guidelines–including word limits (“targets”) and a web guideline supplement for useful but noncritical tables and figures–are 2 such changes. This Preamble is an abbreviated version, with the detailed version available online. The reader is encouraged to consult the full-text guideline for additional guidance and details, since the executive summary contains mainly the recommendations.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Clinical trials are increasingly supported by industries while previous studies have shown that industry-supported studies have more favorable results than studies with other sources of funding. In the present study, we investigated the association of industrial funding on the results of clinical trials regarding chemotherapy in prostate cancer.
Results: In this study, out of the 91 studies, 80.2% were funded by pharmaceutical companies and 19.8% were funded by government agencies. The end result of 61.6% of the studies funded by pharmaceutical companies was an increase in survival due to chemotherapy, whereas only 27.8% of the studies sponsored by government agencies reported positive results (P-value=0.010). In fact, industry-funded trials more often presented statistically significant positive results for survival (OR: 4.17; CI, 1.34-12.99). In general, there was no significant difference in the degree of bias between the two groups. According to this study, despite of the similar quality of studies funded by pharmaceutical companies and government agencies, positive results were more common in studies related to pharmaceutical companies. Therefore, this point should be taken into account when making a decision on the best treatment approach.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: This study aimed to examine multi-stakeholder perceptions regarding the integration of patient input and patient preference information (PPI) across the medical product lifecycle and to identify priority areas and regulatory prerequisites for its effective incorporation in South Korea.
Results: Among 183 respondents, perceived necessity of incorporating patient input was high, whereas current incorporation was rated substantially lower, indicating a clear gap between stakeholder expectations and current practice (p < 0.001). On average across lifecycle stages, respondents from patient organizations reported higher perceived necessity (4.20) than respondents from pharmaceutical (3.39; p < 0.001) and medical device companies (3.62; p = 0.004). Across priority areas, necessity ratings were highest for products requiring direct patient use (4.14) and lowest for contexts involving uncertainty in efficacy or safety (3.42). For uncertainty in efficacy or safety, the medical device company group reported significantly higher ratings than the pharmaceutical company group (3.61 vs 2.91; p = 0.029).
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Exposure-response (ER) analyses assessing the efficacy of large molecule therapeutics are often susceptible to confounding, where associations between drug exposure and patient disease severity can obscure true ER signals and complicate dose selection.
Results: In contrast, the use of advanced statistical methods for causal inference is inconsistent (45.6% usage), and confidence in their reliability is mixed, with 32.8% of respondents expressing uncertainty and most others rating them only moderate or somewhat reliable. While the majority agreed that confounded ER analyses should be interpreted with caution (79.2%), opinions diverged regarding their value in decision-making when dose-ranging data is insufficient. This uncertainty, coupled with a recognized need for additional alignment with health authorities, led to a call for best-practice guidance (92.8% view as valuable). Overall, the survey findings highlight a need for an industry-wide common approach and the development of clear frameworks to manage and interpret ER confounding for large molecule therapeutics.
“Not stated” does not mean nobody paid — the database does not always record it.
What do orthomolecular medicine doctors write?
Sources (17)
- Stowarzyszenie STOP NOP — Przemysł farmaceutyczny fałszuje korzyści i szkodliwość swoich produktów wpływając na system ochrony zdrowia – Ogólnopolskie Stowarzyszenie Wiedzy o Szczepieniach "STOP NOP"
- Jerzy Zięba — Nasze zdrowie w naszych rękach
- Jerzy Zięba — Czy Nowy da radę? Jerzy Zięba
- Stowarzyszenie STOP NOP — Połowa literatury naukowej może być fałszywa – Ogólnopolskie Stowarzyszenie Wiedzy o Szczepieniach "STOP NOP"
- Henryk Różański — Drodzy urzędnicy – Ręce precz od ziół
- Hubert Czerniak — Powstrzymać raka
- Jerzy Zięba — Jak owce na rzeź
- Jerzy Zięba — Uleczalne nieuleczalne
- Physician's prescription and pharmaceutical industry's influence - where have the ethics gone? · J Pak Med Assoc 2024
- Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: the undiscovered country. · J Am Acad Nurse Pract 2005
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. · Circulation 2019
- Pharmaceutical industry funding and chemotherapy trials for prostate cancer: A systematic review. · Cancer Treat Res Commun 2023
- Stakeholder Perspectives on Incorporating Patient Preference Information into Drug and Medical Device Regulatory Decision-Making in Korea. · Patient Prefer Adherence 2026
- Pharmaceutical Industry Perspectives on Exposure-Response Confounding in Large Molecule Therapeutics: Results From an IQ Consortium Survey. · CPT Pharmacometrics Syst Pharmacol 2026
- Orthomolecular Medicine News Service — Regulation of Vitamins: Politics As Usual
- Orthomolecular Medicine News Service — Nutrient Benefit Statements and the 2010 Legal Victory Prohibiting FDA Censorship of Qualified Health Claims
- Orthomolecular Medicine News Service — The Mismanagement of ASCVD: A Call for Root Cause Solutions Beyond Cholesterol
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.